CRYOVALVE SG PULMONARY HEART VALVE AND CONDUIT SGPV00

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2010-09-16 for CRYOVALVE SG PULMONARY HEART VALVE AND CONDUIT SGPV00 manufactured by Cryolife, Inc..

Event Text Entries

[1429489] Approximately seven years after implant of the heart valve, a fungal vegetation reportedly developed in the conduit. However, the surgeon does not believe the organism was introduced by the allograft or at the time of implant.
Patient Sequence No: 1, Text Type: D, B5


[8707270] An investigation into the reported event has been initiated. This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event. Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
Patient Sequence No: 1, Text Type: N, H10


[8847829] According to the report, the patient received pulmonary valve and conduit sg as a replacement for a previously implanted allograft (no record of previous implant) that was explanted due to pulmonary insufficiency. Approximately seven years after implant of the allograft, it was explanted due to fungal vegetations within the allograft. As such, an investigation was performed. A review of the monitoring records indicates that each technician who handled this allograft was appropriately qualified for the task she or he performed. A review of the processing records indicates that this allograft was processed according to applicable procedures. A review of the donor records showed that the donor showed no evidence of systemic infection or disseminated contamination. The cause of the reported event can not be determined from the available information. However, given the time interval between the implant and the reported event, contamination of the graft prior to implant would be exceedingly unlikely. In addition, the surgeon did not feel that the organism was introduced by the allograft. No further action is warranted at this time.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1063481-2010-00035
MDR Report Key1837319
Report Source05
Date Received2010-09-16
Date of Report2010-09-16
Date Mfgr Received2010-09-15
Device Manufacturer Date2002-05-10
Date Added to Maude2010-09-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. BRYAN BROSSEAU
Manufacturer Street1655 ROBERTS BLVD. NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal30144
Manufacturer Phone7704193355
Manufacturer G1CRYOLIFE, INC.
Manufacturer Street1655 ROBERTS BLVD. NW
Manufacturer CityKENNESAW GA 30144
Manufacturer CountryUS
Manufacturer Postal Code30144
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCRYOVALVE SG PULMONARY HEART VALVE AND CONDUIT
Generic NameHEART VALVE
Product CodeOHA
Date Received2010-09-16
Model NumberSGPV00
Lot NumberN/A
Device Expiration Date2012-01-01
OperatorPHYSICIAN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCRYOLIFE, INC.
Manufacturer Address1655 ROBERTS BLVD. NW KENNESAW GA 30144 US 30144


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2010-09-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.